Moleculin Biotech, Inc. · NASDAQ:MBRX
Moleculin Biotech, Inc. shareholders
As of Sep 30, 2026, 21 institutions reported holding Moleculin Biotech, Inc., 59.5% of its shares. Largest: Vanguard, Jane Street and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Moleculin Biotech, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 150K | 14.2% | +78,233 | Nov 13, 2026 |
| Jane Street | 142K | 13.4% | new | Nov 12, 2026 |
| Geode Capital | 105K | 9.9% | +57,418 | Nov 6, 2026 |
| XTX Topco Ltd | 60,775 | 5.7% | +37,833 | Nov 16, 2026 |
| Hrt Financial LP | 60,217 | 5.7% | new | Nov 13, 2026 |
| Big Sioux Wealth Management | 42,927 | 4.0% | first report | Nov 18, 2026 |
| Stratos Wealth Partners, LTD. | 37,538 | 3.5% | new | Nov 13, 2026 |
| Rockefeller Capital Management L.P. | 15,000 | 1.4% | no change | Nov 13, 2026 |
| Susquehanna | 14,586 | 1.4% | new | Nov 16, 2026 |
| Tower Research Capital LLC (TRC) | 1,252 | 0.12% | −2,262 | Nov 16, 2026 |